Correlation Between Oncolytics Biotech and Milestone Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Oncolytics Biotech and Milestone Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncolytics Biotech and Milestone Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncolytics Biotech and Milestone Pharmaceuticals, you can compare the effects of market volatilities on Oncolytics Biotech and Milestone Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncolytics Biotech with a short position of Milestone Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncolytics Biotech and Milestone Pharmaceuticals.
Diversification Opportunities for Oncolytics Biotech and Milestone Pharmaceuticals
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Oncolytics and Milestone is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Oncolytics Biotech and Milestone Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Milestone Pharmaceuticals and Oncolytics Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncolytics Biotech are associated (or correlated) with Milestone Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Milestone Pharmaceuticals has no effect on the direction of Oncolytics Biotech i.e., Oncolytics Biotech and Milestone Pharmaceuticals go up and down completely randomly.
Pair Corralation between Oncolytics Biotech and Milestone Pharmaceuticals
Given the investment horizon of 90 days Oncolytics Biotech is expected to under-perform the Milestone Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Oncolytics Biotech is 1.25 times less risky than Milestone Pharmaceuticals. The stock trades about -0.26 of its potential returns per unit of risk. The Milestone Pharmaceuticals is currently generating about 0.26 of returns per unit of risk over similar time horizon. If you would invest 147.00 in Milestone Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 38.00 from holding Milestone Pharmaceuticals or generate 25.85% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oncolytics Biotech vs. Milestone Pharmaceuticals
Performance |
| Timeline |
| Oncolytics Biotech |
| Milestone Pharmaceuticals |
Oncolytics Biotech and Milestone Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oncolytics Biotech and Milestone Pharmaceuticals
The main advantage of trading using opposite Oncolytics Biotech and Milestone Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncolytics Biotech position performs unexpectedly, Milestone Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Milestone Pharmaceuticals will offset losses from the drop in Milestone Pharmaceuticals' long position.| Oncolytics Biotech vs. Scpharmaceuticals | Oncolytics Biotech vs. Milestone Pharmaceuticals | Oncolytics Biotech vs. Seres Therapeutics | Oncolytics Biotech vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |